<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20221023056272N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-04-29</date_registration>
      <primary_sponsor>Ahvaz University of Medical Sciences</primary_sponsor>
      <public_title>Evaluation the effect of  low level laser therapy in management of the complications after guided bone regeneration(GBR) surgeries.</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of the effect of using low level laser therapy in management of the complications of guided bone regeneration(GBR) surgeries in patients who need this surgery</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-04-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>22</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/66509</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: A list of 22 characters consisting of 11 characters A (representative of the laser radiation group) and 11 characters B (representative of the group without laser radiation (placebo)) is created by simple randomization using the envelope-in-package method, and the  patients are placed in one of groups A or B according to the order of their referral, Blinding description: Participant: For all the people participating in the study, the laser irradiation process is performed , the difference is that for the intervention group, the laser irradiation process is performed with the laser on, and for the control or placebo group, the laser irradiation process is performed with the laser off.

Outcome assessor (clinical examiner): the clinical examiner does the patient's examination without being aware of the patient's group and records the necessary information.

Data analyst: The data analyst or statistical consultant will analyze  the data of each group without knowing witch group is the control and which is the intervention.</study_design>
      <phase>3</phase>
      <hc_freetext>Post-operative complications of guided bone regeneration.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Laser radiation: In the laser radiation group, immediately after the surgery for each patient, the surgical site will be irradiated with Diode laser with a wavelength of 940 nm and a power of 300 mW and 16 seconds for each cm2 of the lesion. The necessary dose for laser therapy is 5 j/〖cm〗^2 (we will have 16 seconds of radiation for each cm2). According to the explained method, the same amount of energy is again irradiated to the desired area 48 hours after the surgery. Intervention 2: Control group: In the control group, laser irradiation is performed with the device turned off at the same time as the intervention group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is Privacy of patient's personal information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Asma Moghadasi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Floor. 2, No. 12, East Elham, Kianpars Street</address>
        <city>Ahwaz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6155843651</zip>
        <telephone>+98 61 3333 5830</telephone>
        <email>asma.moghadasi98@gmail.com</email>
        <affiliation>Ahvaz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Asma Moghadasi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>East elham, kianpars streat, Ahwaz town</address>
        <city>Ahwaz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6155843651</zip>
        <telephone>+98 933 177 4942</telephone>
        <email>moghadasi.a@ajums.ac</email>
        <affiliation>Ahvaz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients must be medically healthy
Having healthy oral mucosa.
Not having the history of implant failure at the surgical site or contraindications for implant placement
Patients must be in need of bone grafting for placement of implant
Cases, with maximum 0.5cc bone powder required  for bone grafting, are going to be chosen
The surgical field should be limited to 1 to 3 teeth
Patients should not use removable prosthesis or similar items
No history of medical conditions that might delay wound healing process such as: diabetes, smoking, and alcohol consumption.</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Lack of Patient's cooperation
Having photosensitivity
Patients who have used antibiotics and corticosteroids for any reason in the last 2 weeks</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>T88.8XXA</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other specified complications of surgical and medical care, not elsewhere classified, initial encounter</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Laser radiation: In the laser radiation group, immediately after the surgery for each patient, the surgical site will be irradiated with Diode laser with a wavelength of 940 nm and a power of 300 mW and 16 seconds for each cm2 of the lesion. The necessary dose for laser therapy is 5 j/〖cm〗^2 (we will have 16 seconds of radiation for each cm2). According to the explained method, the same amount of energy is again irradiated to the desired area 48 hours after the surgery.</i_keyword>
      <i_keyword>Control group: In the control group, laser irradiation is performed with the device turned off at the same time as the intervention group.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The VAS(visual analog scale) number of pain intensity declared by patients. Timepoint: At 12, 24, 48, 72 hours after surgery. Method of measurement: based on VAS (visual analog scale).</prim_outcome>
      <prim_outcome>The assigned number of the hemostasis status. Timepoint: On second day after surgery. Method of measurement: The number assigned to each hemostasis status is based on the following classification: 0 for the presence of bleeding in the wound margin/1 for the presence of fibrin in the wound margin/2 for the absence of fibrin in the wound margin.</prim_outcome>
      <prim_outcome>Determining the degree of wound healing based on assigned numbers. Timepoint: On the seventh day after surgery. Method of measurement: Wound healing is graded as follows: 0 for complete wound healing / 1 for wound healing and the presence of a thin line of fibrinous membrane / 2 for wound healing and the presence of fibrin / 3 for incomplete wound closure and the presence of a gap/ 4 no wound healing (necrosis).</prim_outcome>
      <prim_outcome>Determining the degree of inflammation based on two factors: 1) the degree of redness of the wound margin 2) presence or absence of extraoral swelling. Timepoint: On the second and seventh day after surgery. Method of measurement: To check the redness of the wound margin, the following grading is used: 0 for redness over 50% of the length of the wound margin / 1 for redness less than 50% of the length of the wound margin / 2 no redness.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>The number and dose of painkillers taken by the patient. Timepoint: On seventh day after surgery. Method of measurement: After the surgery, the patient is given a table and asked to make notes in the table after receiving each painkiller. And the table is delivered on the seventh day.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Ahvaz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-04-08</approval_date>
        <contact_name>Ethics committee of Ahwaz University of Medical Sciences</contact_name>
        <contact_address>4th Floor ,No.12, Elham sharghi Street. Kianpars Street Ahwaz Khouzestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
